📑ADQUISICIÓN DE MEDICAMENTOS E INSUMOS PARA LA FARMACIA MUNICIPAL DEL GADMIPA
Procurement process summary
This process is to purchase Adquisición de medicamentos e insumos para la farmacia municipal del gadmipa.
This contract was awarded by 🇪🇨 Gobierno Municipal de Arajuno for an amount of USD 38,656 to 1 supplier. It was published on 2019-10-02 through open and its current status is complete
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇨 Gobierno Municipal de Arajuno Buying unitnot reported Publication date2019-10-02 Contest statuscomplete DescriptionSIE-GADMIPA-2019-07-30228Awards
This award was granted to OFTALVIS S.A. by Gobierno Municipal de Arajuno for an amount of USD 38,656. The procurement process was conducted through open for the category of goods. The contract was signed on 2019-10-29. The award was granted on 2019-10-16.
| Supplier | Amount | Award date |
|---|---|---|
| 🇪🇨 OFTALVIS S.A. | USD 38,656 | 2019-10-16 |
Market context and opportunities
The execution of this contract allows the entity Gobierno Municipal de Arajuno to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEC_ocds-5wno2w-SIE-GADMIPA-2019-07-30228-1525256-SIE-GADMIPA-2019-07Publication date2019-10-02Contract date2019-10-29Award date2019-10-16CategoriesgoodsPurchase modalityopenMethod detailsSubasta Inversa ElectrónicaStatuscompleteData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
